HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 132 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,132,000 | -38.1% | 127,706 | -11.8% | 0.00% | – |
Q2 2022 | $1,829,000 | -31.5% | 144,781 | +2.6% | 0.00% | -100.0% |
Q1 2022 | $2,671,000 | -45.0% | 141,157 | +1.9% | 0.00% | 0.0% |
Q4 2021 | $4,860,000 | -4.3% | 138,554 | -0.1% | 0.00% | 0.0% |
Q3 2021 | $5,080,000 | -3.3% | 138,751 | +3.7% | 0.00% | 0.0% |
Q2 2021 | $5,256,000 | +27.6% | 133,820 | -8.3% | 0.00% | 0.0% |
Q1 2021 | $4,120,000 | +1.7% | 145,853 | +15.2% | 0.00% | 0.0% |
Q4 2020 | $4,053,000 | +1.7% | 126,586 | +2.6% | 0.00% | 0.0% |
Q3 2020 | $3,984,000 | +17.1% | 123,347 | -0.0% | 0.00% | 0.0% |
Q2 2020 | $3,403,000 | +107.9% | 123,362 | +34.6% | 0.00% | 0.0% |
Q1 2020 | $1,637,000 | -27.6% | 91,649 | +1.7% | 0.00% | 0.0% |
Q4 2019 | $2,260,000 | +39.5% | 90,138 | -0.7% | 0.00% | – |
Q3 2019 | $1,620,000 | -14.2% | 90,781 | +5.8% | 0.00% | -100.0% |
Q2 2019 | $1,888,000 | -17.2% | 85,797 | +15.1% | 0.00% | 0.0% |
Q1 2019 | $2,279,000 | +51.0% | 74,529 | +14.1% | 0.00% | – |
Q4 2018 | $1,509,000 | – | 65,330 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERAL ATLANTIC, L.P. | 4,000,000 | $67,760,000 | 1.05% |
M&G INVESTMENT MANAGEMENT LTD | 7,084,834 | $120,442,178 | 0.54% |
Bellevue Group AG | 1,802,963 | $30,584,761 | 0.49% |
AIA Group Ltd | 391,278 | $6,628,249 | 0.32% |
PLATINUM INVESTMENT MANAGEMENT LTD | 182,052 | $3,083,961 | 0.12% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 4,219,168 | $71,472,706 | 0.11% |
Hennion & Walsh Asset Management, Inc. | 51,735 | $876,391 | 0.06% |
Allianz Asset Management GmbH | 1,644,999 | $27,866,283 | 0.05% |
Janney Capital Management LLC | 17,203 | $291 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 193,811 | $3,268 | 0.01% |